Literature DB >> 29935331

Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand.

Warawan Eiamphungporn1, Sakda Yainoy1, Chakornpat Jumderm1, Rachanis Tan-Arsuwongkul1, Surapee Tiengrim1, Visanu Thamlikitkul2.   

Abstract

OBJECTIVES: Historically, colistin has been considered a last-line therapeutic option against multidrug-resistant Gram-negative bacterial infections. However, chromosomally-encoded and plasmid-mediated colistin resistance is increasingly being reported worldwide. Spread of the plasmid-borne colistin resistance gene mcr-1 is of great concern since it can be transferred between bacteria. The aim of this study was to investigate the prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae collected from human clinical specimens in Thailand during 2014-2017.
METHODS: Minimum inhibitory concentrations (MICs) of colistin were determined by the broth microdilution method for 317 non-duplicate Enterobacteriaceae clinical isolates (37 E. coli and 280 K. pneumoniae). All isolates were screened for the mcr-1 gene by PCR.
RESULTS: The colistin MIC50, MIC90 and MIC range for the 37 E. coli isolates were 0.5, 8 and 0.5-32mg/L, respectively. The mcr-1 gene was detected in 11 E. coli isolates (29.7%). Escherichia coli harbouring the mcr-1 gene had a colistin MIC range of 4-32mg/L. The colistin MIC50, MIC90, and MIC range for the 280 K. pneumoniae isolates were 32, >128, and 0.25 to >128mg/L, respectively. The mcr-1 gene was detected in 4 K. pneumoniae isolates (1.4%). Klebsiella pneumoniae harbouring the mcr-1 gene had a colistin MIC range of 4-64mg/L.
CONCLUSIONS: This is the first report on the prevalence of the mcr-1 gene in colistin-resistant E. coli and K. pneumoniae isolated from humans in Thailand. These data provide added insight into the mechanism of colistin resistance among Enterobacteriaceae pathogens.
Copyright © 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colistin resistance gene; Colistin-resistant; Escherichia coli; Klebsiella pneumoniae; Thailand; mcr-1

Mesh:

Substances:

Year:  2018        PMID: 29935331     DOI: 10.1016/j.jgar.2018.06.007

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  16 in total

1.  Updated Prevalence of mcr-Like Genes among Escherichia coli and Klebsiella pneumoniae in the SENTRY Program and Characterization of mcr-1.11 Variant.

Authors:  Lalitagauri M Deshpande; Cory Hubler; Andrew P Davis; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  SuperPolymyxin™ Medium for the Screening of Colistin-Resistant Gram-Negative Bacteria in Stool Samples.

Authors:  Sara M Przybysz; Carlos Correa-Martinez; Robin Köck; Karsten Becker; Frieder Schaumburg
Journal:  Front Microbiol       Date:  2018-11-21       Impact factor: 5.640

3.  Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection.

Authors:  W Wangchinda; N Pati; N Maknakhon; C Seenama; S Tiengrim; V Thamlikitkul
Journal:  Antimicrob Resist Infect Control       Date:  2018-07-17       Impact factor: 4.887

4.  Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli.

Authors:  Subhashree Bharathan; Niranjana Sri Sundaramoorthy; Harini Chandrasekaran; Gagana Rangappa; GaneshPrasad ArunKumar; Siva Bala Subramaniyan; Anbazhagan Veerappan; Saisubramanian Nagarajan
Journal:  Sci Rep       Date:  2019-03-28       Impact factor: 4.379

5.  Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli.

Authors:  Kamonchanok Jitaree; Korbtham Sathirakul; Jantana Houngsaitong; Orarik Asuphon; Weerayuth Saelim; Visanu Thamlikitkul; Preecha Montakantikul
Journal:  Antibiotics (Basel)       Date:  2019-08-22

6.  Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.

Authors:  Julalak C Ontong; Nwabor F Ozioma; Supayang P Voravuthikunchai; Sarunyou Chusri
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

7.  Whole-Genome Sequencing of Clinically Isolated Carbapenem-Resistant Enterobacterales Harboring mcr Genes in Thailand, 2016-2019.

Authors:  Wantana Paveenkittiporn; Watcharaporn Kamjumphol; Ratchadaporn Ungcharoen; Anusak Kerdsin
Journal:  Front Microbiol       Date:  2021-01-11       Impact factor: 5.640

8.  Prevalence of insertion sequence elements in plasmids relating to mgrB gene disruption causing colistin resistance in Klebsiella pneumoniae.

Authors:  Stephen Mark Edward Fordham; Anna Mantzouratou; Elizabeth Sheridan
Journal:  Microbiologyopen       Date:  2022-02       Impact factor: 3.139

9.  Occurrence of mcr-mediated colistin resistance in Salmonella clinical isolates in Thailand.

Authors:  Sirirat Luk-In; Tanittha Chatsuwan; Naris Kueakulpattana; Ubolrat Rirerm; Dhammika Leshan Wannigama; Rongpong Plongla; Ratana Lawung; Chaiwat Pulsrikarn; Siriporn Chantaroj; Pattharaporn Chaichana; Nattida Saksaengsopa; Teerarat Shanthachol; Malee Techapornroong; Sunee Chayangsu; Wanla Kulwichit
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

10.  The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates.

Authors:  Parnrada Nulsopapon; Worapong Nasomsong; Manat Pongchaidecha; Dhitiwat Changpradub; Piraporn Juntanawiwat; Wichai Santimaleeworagun
Journal:  Antibiotics (Basel)       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.